Galectin-1-induced autophagy facilitates cisplatin resistance of hepatocellular carcinoma

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Su, Yu Chi ^a   Davuluri, Goutham Venkata Naga ^a   Chen, Cheng Hao ^a   Shiau, Dong Che ^a   Chen, Chien Chin ^b,c   Chen, Chia Ling ^d   Lin, Yee Shin ^a,e   Chang, Chih Peng ^a,e  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GALECTIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER RESISTANCE; CONTROLLED STUDY; DRUG EFFICACY; HEPATOMA CELL; LIVER CELL CARCINOMA; MALE; MITOPHAGY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; HEP-G2 CELL LINE; HUMAN; LIVER TUMOR; METABOLISM; PATHOLOGY;

ANIMALS; APOPTOSIS; AUTOPHAGY; CARCINOMA, HEPATOCELLULAR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GALECTIN 1; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MITOCHONDRIAL DEGRADATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84959217460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148408     Document Type: Article

References (35)

1. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012; 142(6): 1264-73 e1. Epub 2012/04/28. doi: 10.1053/j.gastro.2011.12.061 PMID: 22537432; PubMed Central PMCID: PMC3338949.
2. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet. 1997; 350(9085): 1142-3. Epub 1997/10/31. doi: 10.1016/S0140-6736(05) 63789-0 PMID: 9343506.
3. Fabregat I. Dysregulation of apoptosis in hepatocellular carcinoma cells. World journal of gastroenterology. 2009; 15(5): 513-20. Epub 2009/02/06. PMID: 19195051; PubMed Central PMCID: PMC2653340.
4. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. The New England journal of medicine. 1999; 340(10): 745-50. Epub 1999/03/11. doi: 10.1056/NEJM199903113401001 PMID: 10072408.
5. El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatology research: The official journal of the Japan Society of Hepatology. 2007; 37 Suppl 2: S88-94. Epub 2007/09/20. doi: 10.1111/j. 1872-034X.2007.00168.x PMID: 17877502.
6. Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, et al. Autophagy and chemotherapy resistance: A promising therapeutic target for cancer treatment. Cell death & disease. 2013; 4: E838. Epub 2013/10/12. doi: 10.1038/cddis.2013.350 PMID: 24113172; PubMed Central PMCID: PMC3824660.
7. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiological reviews. 2010; 90 (4): 1383-435. Epub 2010/10/21. doi: 10.1152/physrev.00030.2009 PMID: 20959619.
8. Yang Z, Klionsky DJ. An overview of the molecular mechanism of autophagy. Current topics in microbiology and immunology. 2009; 335: 1-32. Epub 2009/10/06. doi: 10.1007/978-3-642-00302-8-1 PMID: 19802558; PubMed Central PMCID: PMC2832191.
9. Song YJ, Zhang SS, Guo XL, Sun K, Han ZP, Li R, et al. Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. Cancer letters. 2013; 339(1): 70-81. Epub 2013/07/25. doi: 10.1016/j.canlet.2013.07.021 PMID: 23879969.
10. Xu Y, Yu H, Qin H, Kang J, Yu C, Zhong J, et al. Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer letters. 2012; 314 (2): 232-43. Epub 2011/10/25. doi: 10.1016/j.canlet.2011.09.034 PMID: 22019047.
11. Fong MY, Jin S, Rane M, Singh RK, Gupta R, Kakar SS. Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer. PloS one. 2012; 7(7): E42265. Epub 2012/08/04. doi: 10.1371/journal.pone.0042265 PMID: 22860102; PubMed Central PMCID: PMC3408484.
12. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nature reviews Cancer. 2005; 5(9): 726-34. Epub 2005/09/09. doi: 10.1038/nrc1692 PMID: 16148885.
13. Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer research. 2008; 68(5): 1485-94. Epub 2008/03/05. doi: 10.1158/0008-5472.CAN-07-0562 PMID: 18316613.
14. Hughes RC. Galectins as modulators of cell adhesion. Biochimie. 2001; 83(7): 667-76. Epub 2001/08/28. PMID: 11522396.
15. Hikita C, Vijayakumar S, Takito J, Erdjument-Bromage H, Tempst P, Al-Awqati Q. Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin 3. The Journal of cell biology. 2000; 151(6): 1235-46. Epub 2000/12/21. PMID: 11121438; PubMed Central PMCID: PMC2190595.
16. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nature reviews Cancer. 2005; 5(1): 29-41. Epub 2005/01/05. doi: 10.1038/nrc1527 PMID: 15630413.
17. Yeh CC, Hsu CH, Shao YY, Ho WC, Tsai MH, Feng WC, et al. Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer. Molecular & cellular proteomics: MCP. 2015; 14(6): 1527-45. Epub 2015/04/09. doi: 10.1074/mcp.M114.046417 PMID: 25850433; PubMed Central PMCID: PMC4458718.
18. Zhang P, Shi B, Zhou M, Jiang H, Zhang H, Pan X, et al. Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer. Cell death & disease. 2014; 5: E991. Epub 2014/01/11. doi: 10.1038/cddis.2013.526 PMID: 24407244; PubMed Central PMCID: PMC4040687.
19. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, et al. Galectins: A family of animal beta-galactoside-binding lectins. Cell. 1994; 76(4): 597-8. Epub 1994/02/25. PMID: 8124704.
20. Chang CP, Yang MC, Liu HS, Lin YS, Lei HY. Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model. Hepatology. 2007; 45(2): 286-96. Epub 2007/01/30. doi: 10.1002/hep.21509 PMID: 17256764.
21. Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX, et al. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. Journal of gastroenterology and hepatology. 2012; 27(8): 1312-9. Epub 2012/03/22. doi: 10.1111/j.1440-1746.2012.07130.x PMID: 22432916.
22. Espelt MV, Croci DO, Bacigalupo ML, Carabias P, Manzi M, Elola MT, et al. Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth. Hepatology. 2011; 53 (6): 2097-106. Epub 2011/03/11. doi: 10.1002/hep.24294 PMID: 21391228.
23. Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 2007; 3(5): 452-60. Epub 2007/05/31. PMID: 17534139.
24. Wang K, Klionsky DJ. Mitochondria removal by autophagy. Autophagy. 2011; 7(3): 297-300. Epub 2011/01/22. PMID: 21252623; PubMed Central PMCID: PMC3359476.
25. Guo XL, Li D, Hu F, Song JR, Zhang SS, Deng WJ, et al. Targeting autophagy potentiates chemotherapy- induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer letters. 2012; 320 (2): 171-9. Epub 2012/03/13. doi: 10.1016/j.canlet.2012.03.002 PMID: 22406827.
26. Chang CP, Su YC, Hu CW, Lei HY. TLR2-dependent selective autophagy regulates NF-kappaB lysosomal degradation in hepatoma-derived M2 macrophage differentiation. Cell death and differentiation. 2013; 20(3): 515-23. Epub 2012/11/24. doi: 10.1038/cdd.2012.146 PMID: 23175187; PubMed Central PMCID: PMC3569990.
27. Ando E, Tanaka M, Yamashita F, Kuromatsu R, Yutani S, Fukumori K, et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: Analysis of 48 cases. Cancer. 2002; 95(3): 588-95. Epub 2002/09/05. doi: 10.1002/cncr.10694 PMID: 12209752.
28. Chung LY, Tang SJ, Sun GH, Chou TY, Yeh TS, Yu SL, et al. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clinical cancer research: An official journal of the American Association for Cancer Research. 2012; 18(15): 4037-47. Epub 2012/06/15. doi: 10.1158/1078-0432.CCR-11-3348 PMID: 22696230.
29. Thurston TL, Wandel MP, von Muhlinen N, Foeglein A, Randow F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature. 2012; 482(7385): 414-8. Epub 2012/01/17. doi: 10.1038/nature10744 PMID: 22246324; PubMed Central PMCID: PMC3343631.
30. Murata T, Hibasami H, Maekawa S, Tagawa T, Nakashima K. Preferential binding of cisplatin to mitochondrial DNA and suppression of ATP generation in human malignant melanoma cells. Biochemistry international. 1990; 20(5): 949-55. Epub 1990/01/01. PMID: 2112385.
31. Hirama M, Isonishi S, Yasuda M, Ishikawa H. Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells. Oncology reports. 2006; 16(5): 997-1002. Epub 2006/10/04. PMID: 17016583.
32. Sun Y, Liu JH, Jin L, Sui YX, Lai L, Yang Y. Inhibition of Beclin 1 expression enhances cisplatin-induced apoptosis through a mitochondrial-dependent pathway in human ovarian cancer SKOV3/DDP cells. Oncology research. 2014; 21(5): 261-9. Epub 2014/05/24. doi: 10.3727/096504014X13946388748992 PMID: 24854102.
33. Chourasia AH, Macleod KF. Tumor suppressor functions of BNIP3 and mitophagy. Autophagy. 2015; 11(10): 1937-8. Epub 2015/09/01. doi: 10.1080/15548627.2015.1085136 PMID: 26315353.
34. Mathieu V, de Lassalle EM, Toelen J, Mohr T, Bellahcene A, Van Goietsenoven G, et al. Galectin-1 in melanoma biology and related neo-angiogenesis processes. The Journal of investigative dermatology. 2012; 132(9): 2245-54. Epub 2012/05/25. doi: 10.1038/jid.2012.142 PMID: 22622427.
35. Jones TW, Chopra S, Kaufman JS, Flamenbaum W, Trump BF. Cis-diamminedichloroplatinum (II)- induced acute renal failure in the rat. Correlation of structural and functional alterations. Laboratory investigation; a journal of technical methods and pathology. 1985; 52(4): 363-74. Epub 1985/04/01. PMID: 4039014.